Literature DB >> 29545337

RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells.

David Vallois1, Aurélie Dupuy2, Francois Lemonnier2,3, George Allen1, Edoardo Missiaglia1, Virginie Fataccioli2,4, Nicolas Ortonne2,4, Aline Clavert5, Richard Delarue6, Marie-Christine Rousselet7, Bettina Fabiani8, Francisco Llamas-Gutierrez9, Seishi Ogawa10, Margot Thome11, Young Hyeh Ko12, Keisuke Kataoka10, Philippe Gaulard2,4, Laurence de Leval13.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29545337      PMCID： PMC6068042          DOI： 10.3324/haematol.2017.186767

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.

Authors:  J Rohr; S Guo; J Huo; A Bouska; C Lachel; Y Li; P D Simone; W Zhang; Q Gong; C Wang; A Cannon; T Heavican; A Mottok; S Hung; A Rosenwald; R Gascoyne; K Fu; T C Greiner; D D Weisenburger; J M Vose; L M Staudt; W Xiao; G E O Borgstahl; S Davis; C Steidl; T McKeithan; J Iqbal; W C Chan
Journal:  Leukemia       Date:  2015-12-31       Impact factor: 11.528

2.  Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets.

Authors:  Laurence de Leval; Marie Parrens; Fabien Le Bras; Jean-Philippe Jais; Virginie Fataccioli; Antoine Martin; Laurence Lamant; Richard Delarue; Françoise Berger; Flavie Arbion; Céline Bossard; Marie-Christine Copin; Danielle Canioni; Frédéric Charlotte; Gandhi Damaj; Peggy Dartigues; Bettina Fabiani; Albane Ledoux-Pilon; Karine Montagne; Thierry Molina; Martine Patey; Patrick Tas; Michel Peoch; Barbara Petit; Tony Petrella; Jean-Michel Picquenot; Thérèse Rousset; Marie-Christine Rousselet; Isabelle Soubeyran; Sylvie Thiebault; Olivier Tournilhac; Luc Xerri; Christian Gisselbrecht; Corinne Haioun; Georges Delsol; Philippe Gaulard
Journal:  Haematologica       Date:  2015-06-04       Impact factor: 9.941

3.  Integrated molecular analysis of adult T cell leukemia/lymphoma.

Authors:  Keisuke Kataoka; Yasunobu Nagata; Akira Kitanaka; Yuichi Shiraishi; Teppei Shimamura; Jun-Ichirou Yasunaga; Yasushi Totoki; Kenichi Chiba; Aiko Sato-Otsubo; Genta Nagae; Ryohei Ishii; Satsuki Muto; Shinichi Kotani; Yosaku Watatani; June Takeda; Masashi Sanada; Hiroko Tanaka; Hiromichi Suzuki; Yusuke Sato; Yusuke Shiozawa; Tetsuichi Yoshizato; Kenichi Yoshida; Hideki Makishima; Masako Iwanaga; Guangyong Ma; Kisato Nosaka; Masakatsu Hishizawa; Hidehiro Itonaga; Yoshitaka Imaizumi; Wataru Munakata; Hideaki Ogasawara; Toshitaka Sato; Ken Sasai; Kenzo Muramoto; Marina Penova; Takahisa Kawaguchi; Hiromi Nakamura; Natsuko Hama; Kotaro Shide; Yoko Kubuki; Tomonori Hidaka; Takuro Kameda; Tsuyoshi Nakamaki; Ken Ishiyama; Shuichi Miyawaki; Sung-Soo Yoon; Kensei Tobinai; Yasushi Miyazaki; Akifumi Takaori-Kondo; Fumihiko Matsuda; Kengo Takeuchi; Osamu Nureki; Hiroyuki Aburatani; Toshiki Watanabe; Tatsuhiro Shibata; Masao Matsuoka; Satoru Miyano; Kazuya Shimoda; Seishi Ogawa
Journal:  Nat Genet       Date:  2015-10-05       Impact factor: 38.330

4.  Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.

Authors:  François Lemonnier; Lucile Couronné; Marie Parrens; Jean-Philippe Jaïs; Marion Travert; Laurence Lamant; Olivier Tournillac; Therese Rousset; Bettina Fabiani; Rob A Cairns; Tak Mak; Christian Bastard; Olivier A Bernard; Laurence de Leval; Philippe Gaulard
Journal:  Blood       Date:  2012-07-03       Impact factor: 22.113

Review 5.  Molecular mechanisms of T cell co-stimulation and co-inhibition.

Authors:  Lieping Chen; Dallas B Flies
Journal:  Nat Rev Immunol       Date:  2013-03-08       Impact factor: 53.106

6.  Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.

Authors:  David Vallois; Maria Pamela D Dobay; Ryan D Morin; François Lemonnier; Edoardo Missiaglia; Mélanie Juilland; Justyna Iwaszkiewicz; Virginie Fataccioli; Bettina Bisig; Annalisa Roberti; Jasleen Grewal; Julie Bruneau; Bettina Fabiani; Antoine Martin; Christophe Bonnet; Olivier Michielin; Jean-Philippe Jais; Martin Figeac; Olivier A Bernard; Mauro Delorenzi; Corinne Haioun; Olivier Tournilhac; Margot Thome; Randy D Gascoyne; Philippe Gaulard; Laurence de Leval
Journal:  Blood       Date:  2016-07-01       Impact factor: 22.113

7.  Frequent CTLA4-CD28 gene fusion in diverse types of T-cell lymphoma.

Authors:  Hae Yong Yoo; Pora Kim; Won Seog Kim; Seung Ho Lee; Sangok Kim; So Young Kang; Hye Yoon Jang; Jong-Eun Lee; Jaesang Kim; Seok Jin Kim; Young Hyeh Ko; Sanghyuk Lee
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

8.  Genomic profiling of Sézary syndrome identifies alterations of key T cell signaling and differentiation genes.

Authors:  Linghua Wang; Xiao Ni; Kyle R Covington; Betty Y Yang; Jessica Shiu; Xiang Zhang; Liu Xi; Qingchang Meng; Timothy Langridge; Jennifer Drummond; Lawrence A Donehower; Harshavardhan Doddapaneni; Donna M Muzny; Richard A Gibbs; David A Wheeler; Madeleine Duvic
Journal:  Nat Genet       Date:  2015-11-09       Impact factor: 38.330

9.  Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.

Authors:  Mamiko Sakata-Yanagimoto; Terukazu Enami; Kenichi Yoshida; Yuichi Shiraishi; Ryohei Ishii; Yasuyuki Miyake; Hideharu Muto; Naoko Tsuyama; Aiko Sato-Otsubo; Yusuke Okuno; Seiji Sakata; Yuhei Kamada; Rie Nakamoto-Matsubara; Nguyen Bich Tran; Koji Izutsu; Yusuke Sato; Yasunori Ohta; Junichi Furuta; Seiichi Shimizu; Takuya Komeno; Yuji Sato; Takayoshi Ito; Masayuki Noguchi; Emiko Noguchi; Masashi Sanada; Kenichi Chiba; Hiroko Tanaka; Kazumi Suzukawa; Toru Nanmoku; Yuichi Hasegawa; Osamu Nureki; Satoru Miyano; Naoya Nakamura; Kengo Takeuchi; Seishi Ogawa; Shigeru Chiba
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 41.307

10.  Personalized treatment of Sézary syndrome by targeting a novel CTLA4:CD28 fusion.

Authors:  Aleksandar Sekulic; Winnie S Liang; Waibhav Tembe; Tyler Izatt; Semyon Kruglyak; Jeffrey A Kiefer; Lori Cuyugan; Victoria Zismann; Christophe Legendre; Mark R Pittelkow; John J Gohmann; Fernando R De Castro; Jeffrey Trent; John Carpten; David W Craig; Timothy K McDaniel
Journal:  Mol Genet Genomic Med       Date:  2014-11-27       Impact factor: 2.183
View more
  10 in total

1.  Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

Authors:  Tayla B Heavican; Alyssa Bouska; Jiayu Yu; Waseem Lone; Catalina Amador; Qiang Gong; Weiwei Zhang; Yuping Li; Bhavana J Dave; Maarja-Liisa Nairismägi; Timothy C Greiner; Julie Vose; Dennis D Weisenburger; Cynthia Lachel; Chao Wang; Kai Fu; Jadd M Stevens; Soon Thye Lim; Choon Kiat Ong; Randy D Gascoyne; Edoardo Missiaglia; Francois Lemonnier; Corinne Haioun; Sylvia Hartmann; Martin Bjerregård Pedersen; Maria Antonella Laginestra; Ryan A Wilcox; Bin Tean Teh; Noriaki Yoshida; Koichi Ohshima; Masao Seto; Andreas Rosenwald; German Ott; Elias Campo; Lisa M Rimsza; Elaine S Jaffe; Rita M Braziel; Francesco d'Amore; Giorgio Inghirami; Francesco Bertoni; Laurence de Leval; Philippe Gaulard; Louis M Staudt; Timothy W McKeithan; Stefano Pileri; Wing C Chan; Javeed Iqbal
Journal:  Blood       Date:  2019-02-19       Impact factor: 22.113

Review 2.  Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality.

Authors:  Adrien Krug; Gamze Tari; Aymen Saidane; Philippe Gaulard; Jean-Ehrland Ricci; François Lemonnier; Els Verhoeyen
Journal:  Cancers (Basel)       Date:  2022-05-12       Impact factor: 6.575

3.  Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.

Authors:  Laurence de Leval; Philippe Gaulard; Alina Nicolae; Justine Bouilly; Diane Lara; Virginie Fataccioli; François Lemonnier; Fanny Drieux; Marie Parrens; Cyrielle Robe; Elsa Poullot; Bettina Bisig; Céline Bossard; Audrey Letourneau; Edoardo Missiaglia; Christophe Bonnet; Vanessa Szablewski; Alexandra Traverse-Glehen; Marie-Hélène Delfau-Larue
Journal:  Mod Pathol       Date:  2022-03-17       Impact factor: 8.209

Review 4.  Peripheral T cell lymphomas: from the bench to the clinic.

Authors:  Danilo Fiore; Luca Vincenzo Cappelli; Alessandro Broccoli; Pier Luigi Zinzani; Wing C Chan; Giorgio Inghirami
Journal:  Nat Rev Cancer       Date:  2020-04-06       Impact factor: 60.716

5.  Genomic landscape of young ATLL patients identifies frequent targetable CD28 fusions.

Authors:  Noriaki Yoshida; Kay Shigemori; Nicholas Donaldson; Christopher Trevisani; Nicolas A Cordero; Kristen E Stevenson; Xia Bu; Fumiko Arakawa; Mai Takeuchi; Koichi Ohshima; Akinori Yoda; Samuel Y Ng; David M Weinstock
Journal:  Blood       Date:  2020-04-23       Impact factor: 22.113

Review 6.  Comprehensive genomic analysis identifying heterogeneity in peripheral T-cell lymphoma.

Authors:  Noriaki Yoshida; Kyohei Yamada; Koichi Ohshima
Journal:  Cancer Sci       Date:  2021-02-25       Impact factor: 6.716

7.  Clinicopathological significance of CD28 overexpression in adult T-cell leukemia/lymphoma.

Authors:  Yuma Sakamoto; Takashi Ishida; Ayako Masaki; Morishige Takeshita; Hiromi Iwasaki; Kentaro Yonekura; Yukie Tashiro; Asahi Ito; Shigeru Kusumoto; Shinsuke Iida; Atae Utsunomiya; Ryuzo Ueda; Hiroshi Inagaki
Journal:  Cancer Sci       Date:  2021-11-29       Impact factor: 6.716

Review 8.  Tumor microenvironment of adult T-cell leukemia/lymphoma.

Authors:  Mai Takeuchi; Hiroaki Miyoshi; Koichi Ohshima
Journal:  J Clin Exp Hematop       Date:  2021

Review 9.  New preclinical models for angioimmunoblastic T-cell lymphoma: filling the GAP.

Authors:  Rana Mhaidly; Adrien Krug; Philippe Gaulard; François Lemonnier; Jean-Ehrland Ricci; Els Verhoeyen
Journal:  Oncogenesis       Date:  2020-08-14       Impact factor: 7.485

10.  Clinical significance of CD28 gene-related activating alterations in adult T-cell leukaemia/lymphoma.

Authors:  Yuma Sakamoto; Takashi Ishida; Ayako Masaki; Morishige Takeshita; Hiromi Iwasaki; Kentaro Yonekura; Yukie Tashiro; Asahi Ito; Shigeru Kusumoto; Atae Utsunomiya; Shinsuke Iida; Ryuzo Ueda; Hiroshi Inagaki
Journal:  Br J Haematol       Date:  2020-11-18       Impact factor: 6.998
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.